We are live on ! Find out more
SC

Sculptor Capital Portfolio holdings

AUM $9.61B
1-Year Est. Return 27.49%
This Fund
S&P 500
This Quarter Est. Return
+4.19%
1 Year Est. Return
+27.49%
3 Year Est. Return
+96.6%
5 Year Est. Return
+118.13%
10 Year Est. Return
+298.34%
AUM
$19B
AUM Growth
+$2.11B
Cap. Flow
+$682M
Cap. Flow %
3.6%
Top 10 Hldgs %
60.3%
Holding
324
New
91
Increased
47
Reduced
42
Closed
48

Top Buys

Rank Stock Value
1
UBER icon
Uber
UBER
+$267M
2
BABA icon
Alibaba
BABA
+$251M
3
NFLX icon
Netflix
NFLX
+$225M
4
APC
Anadarko Petroleum
APC
+$168M
5
AGN
Allergan plc
AGN
+$125M

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$162M
2
TMUS icon
T-Mobile US
TMUS
+$109M
3
LOW icon
Lowe's Companies
LOW
+$101M
4
HLT icon
Hilton Worldwide
HLT
+$101M
5
ELAN icon
Elanco Animal Health
ELAN
+$67.2M

Sector Composition

Rank Sector Weight
1 Technology 10.65%
2 Communication Services 7.17%
3 Consumer Discretionary 6.76%
4 Financials 4%
5 Healthcare 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRNA icon
176
Moderna
MRNA
$22.1B
$1.23M 0.01%
84,100
– –
MRNA icon
177
PUT
Moderna
MRNA
$22.1B
$1.23M 0.01%
84,100
– –
TEUM
178
DELISTED
Pareteum Corporation
TEUM
$1.22M 0.01%
+468,000
New +$1.85M
ZYNE
179
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$1.22M 0.01%
89,700
– –
ZYNE
180
PUT
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$1.22M 0.01%
89,700
– –
CRBP icon
181
Corbus Pharmaceuticals
CRBP
$168M
$1.04M 0.01%
5,000
– –
CRBP icon
182
PUT
Corbus Pharmaceuticals
CRBP
$168M
$1.04M 0.01%
5,000
– –
AMRS
183
DELISTED
Amyris Inc.
AMRS
$1M 0.01%
281,100
– –
AMRS
184
PUT
DELISTED
Amyris Inc.
AMRS
$1M 0.01%
281,100
– –
NEPT
185
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$982K 0.01%
161
– –
NEPT
186
PUT
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$982K 0.01%
161
– –
APHA
187
PUT
DELISTED
Aphria Inc. Common Shares
APHA
$958K 0.01%
136,700
+61,600
+82% +$466K
QTWO icon
188
Q2 Holdings
QTWO
$3.64B
$947K 0.01%
+12,400
New +$897K
EOLS icon
189
PUT
Evolus
EOLS
$407M
$925K ﹤0.01%
63,300
-3,000
-5% -$59.5K
EOLS icon
190
Evolus
EOLS
$407M
$826K ﹤0.01%
56,500
-22,000
-28% -$436K
MLNT
191
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$821K ﹤0.01%
+123,500
New +$470K
PGEN icon
192
CALL
Precigen
PGEN
$1.93B
$820K ﹤0.01%
+107,000
New +$576K
MLNT
193
PUT
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$788K ﹤0.01%
+118,500
New +$451K
AAOI icon
194
Applied Optoelectronics
AAOI
$7.85B
$758K ﹤0.01%
73,700
– –
AAOI icon
195
PUT
Applied Optoelectronics
AAOI
$7.85B
$758K ﹤0.01%
73,700
– –
CYRX icon
196
CryoPort
CYRX
$764M
$751K ﹤0.01%
41,000
+21,000
+105% +$333K
CYRX icon
197
PUT
CryoPort
CYRX
$764M
$751K ﹤0.01%
41,000
+21,000
+105% +$333K
STOK icon
198
Stoke Therapeutics
STOK
$1.83B
$729K ﹤0.01%
+25,000
New +$671K
GTT
199
DELISTED
GTT Communications, Inc.
GTT
$711K ﹤0.01%
40,400
– –
GTT
200
PUT
DELISTED
GTT Communications, Inc.
GTT
$711K ﹤0.01%
40,400
– –
6 7
8
9 10

Similar funds

TCA
Tortoise Capital Advisors Overland Park, Kansas $9.6B AUM 19.53% 1-Year Est. Return
DPIM
Duff & Phelps Investment Management Chicago, Illinois $9.63B AUM 11.3% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
CCMT
CMT Capital Markets Trading Frankfurt, Germany $9.56B AUM 21.2% 1-Year Est. Return
LAMI
Longview Asset Management (Illinois) Chicago, Illinois $9.56B AUM 25.94% 1-Year Est. Return
BAMF
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $9.55B AUM 31.94% 1-Year Est. Return
CIM
Centersquare Investment Management Conshohocken, Pennsylvania $9.67B AUM 5.55% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Sculptor Capital's Q2 2019 Portfolio in Review

As of Q2 2019, Sculptor Capital held 324 positions worth $19B, up 13% from $16.8B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Sculptor Capital deployed $682M of net new capital in Q2 2019, opening 91 new positions and adding to 47 existing holdings. Its largest new stake was Uber: 6,287,663 shares worth $289M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was NXP Semiconductors, an estimated $162M trimmed.

  • Sculptor Capital's largest Q2 2019 buy was Uber: 6,287,663 shares worth $289M.
  • Sculptor Capital added most to Alphabet (Google) Class A in Q2 2019, an estimated $98.1M increase.
  • Sculptor Capital's biggest Q2 2019 reduction was NXP Semiconductors, cutting an estimated $162M.
  • Sculptor Capital fully exited Elanco Animal Health in Q2 2019, selling an estimated $67.2M.
  • Sculptor Capital's ten largest holdings make up 60% of its $19B portfolio in Q2 2019.
  • Sculptor Capital opened 91 new positions and closed 48 in Q2 2019.
  • Sculptor Capital's portfolio value rose 13% quarter-over-quarter to $19B.

Based on Sculptor Capital's 13F filing for Q2 2019, filed 14 Aug 2019.